findmyKOL

Julia Haller, MD

Enriched profile

Wills Eye Hospital

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Philadelphia, PA · Northeast · United StatesSpecialtyOphthalmologyFocusRetinal Diseases and Treatments+4
Active KOLfindmyKOL type: EliteLatest publication2022Online presenceverified 2026Payments2021–2025NIH funding2010–2018

Julia Haller is a Retinal Diseases and Treatments physician affiliated with Wills Eye Hospital. OpenAlex indexes 505 publications with 22,085 citations (h-index 71); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the findmyKOL directory.

Data verified 15 Oct 2026

Overview

Updated 16 Oct 2026

Julia Haller, M.D., is affiliated with Wills Eye Hospital. The public record shows 505 publications with 22,085 citations (h-index 71), centered on Retinal Diseases and Treatments, Retinal and Macular Surgery, Retinal and Optic Conditions. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 7 companies, 2 NIH-funded awards (2010–2018).

  • Most recent indexed publication: 2022 · Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
  • Top research focus: Retinal Diseases and Treatments
  • 7 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 7 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Diabetic Complications5 trialsDiabetic Retinopathy / DME5 trialsDiabetic Retinopathy5 trialsGlaucoma2 trialsComa2 trialsRetinal Vein Occlusion2 trialsMacular Degeneration (AMD)1 trialEdema1 trialMacular Edema1 trialType 2 Diabetes1 trialMultiple Sclerosis1 trialWounds and Injuries1 trialOptic Nerve Diseases1 trialOptic Neuropathy, Ischemic1 trialHypertension1 trialCataract1 trialOcular Hypertension1 trialArterial Occlusive Diseases1 trialRetinal Artery Occlusion1 trial

Research focus

OpenAlex concept fingerprint
Retinal Diseases and TreatmentsRetinal and Macular SurgeryRetinal and Optic ConditionsRetinal Imaging and AnalysisGlaucoma and retinal disorders

Drugs & molecules

across trials, industry payments and publications
Eyleageneric · AfliberceptClinical trials—Industry payments4Publications4

Works with

trial sponsors and companies reporting payments
Bristol Myers Squibb CompanyClinical trials—Industry payments179E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments40Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments13Bausch & Lomb Americas Inc.Clinical trials—Industry payments10Wills EyeClinical trials4Industry payments—Alcon Vision LLCClinical trials—Industry payments1Brian Burke, MPHClinical trials1Industry payments—Genentech, Inc.Clinical trials—Industry payments1Jaeb Center for Health ResearchClinical trials1Industry payments—Janssen Global Services, LLCClinical trials—Industry payments1Julia HallerClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
505publications

Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.

22,085citations

Total citations across indexed works.

71h-index

Hirsch index (OpenAlex). i10-index 259.

Clinical & industry

trials, payments and federal funding
7clinical trials

Investigator role on registered studies.

View trials ↓
7companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 2010–2018

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    96.2%
    Vascular Endothelial Growth Factor Inhibitor96.2%
    Aflibercept100%
    Part B, office-administered≥42 patients
  • Sensory organs

    3.8%
    Corticosteroid3.8%
    Prednisolone Acetate100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

2 NIH research awards on record, funded 2010–2018 per NIH RePORTER. The latest:

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Lisa Hark49Ann P. Murchison39Joan W. Miller32Peter A. Campochiaro28Quan Dong Nguyen28Leslie Hyman27Aaron Lee26Anja Lorch26Suzann Pershing25Flora Lum25John J. White25Cecilia S. Lee23Benjamin E. Leiby22Jeffrey S. Heier21Syed Mahmood Shah20Mark S. Blumenkranz18Scott M. Whitcup17Paul M. Colombani16Ingrid Zimmer-Galler16Carl D. Regillo16George A. Williams16Allen C. Ho15Tobias Elze15David S. Boyer15James L. Talbert15Emily Y. Chew14Jeffrey Henderer13Michael Waisbourd13Dennis W. Shermeta13Laura Pizzi13Khan Ma12Jonathan S. Myers12Robin J. Casten12Baruch D. Kuppermann12V. Diana12L. Jay Katz12Barry W. Rovner11Cynthia Owsley11Robert Vitti11David S. Friedman11

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/julia-haller-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/profile/Julia-Haller-2

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.